Codex DNA (NASDAQ:DNAY) CEO Todd Nelson Details the Investment Opportunity for mRNA and DNA Replication

Todd Nelson, CEO, describes Codex DNA (NASDAQ:DNAY) in this 1,921 word interview, exclusively in the Wall Street Transcript.

Related Keywords

Toddr Nelson ,Todd Nelson ,Bioscience Inc ,Codex Dna Inc ,Tcrx Corporation ,Discoverx Corporation ,Nasdaq ,Pfizer ,Global Head Of Life Sciences ,Carlson School Of Business ,University Of Minnesota ,Merrill Lynch Co ,Tonbo Biosciences Corporation ,Mp Biomedicals ,Global Corporate Development ,Nelson Details ,Investment Opportunity ,Chief Executive Officer ,Vice President ,Life Technologies ,Thermo Fisher Scientific ,First Vice President Global Securities ,Merrill Lynch ,Global Head ,Life Sciences ,Carlson School ,Mayo Clinic ,Wall Street Transcript ,Wall Street ,